NCT03164005View on ClinicalTrials.gov

The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease

CompletedOBSERVATIONAL
Enrollment

194

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

September 1, 2017

Study Completion Date

March 1, 2018

Conditions
ObesityMetabolic Disease
Trial Locations (1)

Unknown

Department of Endocrinology, Union Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT03164005 - The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease | Biotech Hunter | Biotech Hunter